Status:
COMPLETED
Enhancement of Behavioral and Cognitive Outcomes in Autism Spectrum Disorder Via Neurostimulation
Lead Sponsor:
Christiana Care Health Services
Collaborating Sponsors:
Dupont Applied Biosciences
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
5-25 years
Phase:
NA
Brief Summary
Autism spectrum disorder (ASD) encompasses a range of limitations in reciprocal social and communicative milestones, as well as restrictive and/or repetitive patterns of behavior which lead to signifi...
Detailed Description
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neurostimulation technique that alters cortical excitability by repeated induction of electromagnetic activity. FDA approved for d...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Fulfilling the Diagnostic and Statistical Manual for Mental Disorders 5th edition (DSM-V) criteria for ASD and confirmed by Gilliam Asperger Disorder Scale (GADS)
- The patient exhibiting adequate understanding and cooperation for the procedure
- Exclusion criteria
- Patients with ASD exhibiting significant anxiety or contact avoidance, precluding them from cooperating with the procedure
- Children with a known diagnosis of seizures
- Presence of any metallic implants or devices in the head or neck area
- Pregnant women
Exclusion
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05371912
Start Date
March 15 2022
End Date
February 1 2024
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mitra Assadi
Newark, Delaware, United States, 19713